mRNA & LNP Contract Testing, Development, & Manufacturing Services
Responding to Patients Needs by Getting mRNA-Based Vaccines and Therapeutics on the Fast Track
As part of our Millipore® CTDMO Services offering, we pave the way for robust, integrated, and consistent processes along all stages from pre-clinical to commercialization. Bringing together our capabilities, technical expertise, and regulatory know-how, we enable our clients to achieve their goals— to get mRNA-based vaccines and therapeutics on the fast track and change the life of patients.
With Millipore® CTDMO Services we offer customized services to help clients accelerate their projects, mitigate risks, and expedite time to market – all the way from mRNA through lipids and lipid nanoparticles (LNP) to final Fill and Finish.
Our Track Record
20+
Years combined track record in mRNA, Lipids and LNP manufacturing
10,000
Fold less pDNA required through next generation PCR based mRNA manufacturing
50+
Individual projects successfully delivered in synthesizing lipids
6
Commercial drug products manufactured
6+
Highly connected sites ensuring speed, scalability, quality, and flexibility
Our Offering
A Global Footprint
We are a single organization with a global network to deliver CDMO services across all stages of the molecule value chain.
A highly connected CDMO network to ensure speed, scalability, quality, and flexibility for mRNA, lipid, and LNP manufacturing.
Our Center of Excellence for Late Clinical & Commercial mRNA, manufacturing sites for our Portfolio Lipids, including Large Scale Lipid Production and Early Formulation Screening Service
Our Center of Excellence for Early Clinical mRNA
Our Center of Excellence specialized for synthesizing high quality Portfolio & Custom Lipids
Our Center of Excellence for the manufacturing of Lipid Nanoparticles (incl. Fill & Finish)
Manufacturing Site for Portfolio & Custom Lipids and Process Development for Liposomes & LNPs
Related Technical Resources
- Strategies for Successful Formulation Development of Lipid-Based RNA Delivery and Vaccines
Here, we explore lipid-based RNA therapeutic development, specifically application opportunities and the performance-defining parameters.
External Resources
- Successful Drug Development with Synthetic Lipids - Critical Aspects and Strategies
Learn more about the essential aspects and strategies of successful drug development and commercialization of lipid-based drug products.
To continue reading please sign in or create an account.
Don't Have An Account?